货号：GS40705
Telazorlimab (GBR-830) is a humanized IgG1 kappa monoclonal antibody targeting OX40 (CD134), a co-stimulatory receptor on activated T cells. It functions as an agonist, binding to OX40 to enhance T cell proliferation, cytokine production, and effector function, thereby boosting anti-tumor immunity. It is being developed for cancer immunotherapy, often in combination with checkpoint inhibitors, for the treatment of advanced solid tumors.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook，有助于交易顺利完成！
冉凯凯